Identify potent SARS-CoV-2 main protease inhibitors via accelerated free energy perturbation-based virtual screening of existing drugs

The COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a global crisis. There is no therapeutic treatment specific for COVID-19. It is highly desirable to identify potential antiviral agents against SARS-CoV-2 from existing drugs available for other d...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zhe, Li, Xin, Huang, Yi-You, Wu, Yaoxing, Liu, Runduo, Zhou, Lingli, Lin, Yuxi, Wu, Deyan, Zhang, Lei, Liu, Hao, Xu, Ximing, Yu, Kunqian, Zhang, Yuxia, Cui, Jun, Zhan, Chang-Guo, Wang, Xin, Luo, Hai-Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: National Academy of Sciences 2020
Materias:
Biological Sciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7959488/
https://www.ncbi.nlm.nih.gov/pubmed/33051297
http://dx.doi.org/10.1073/pnas.2010470117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7959488/
https://www.ncbi.nlm.nih.gov/pubmed/33051297
http://dx.doi.org/10.1073/pnas.2010470117

Ejemplares similares